Synergistic effects of metformin, resveratrol, and hydroxymethylbutyrate on insulin sensitivity

Antje Bruckbauer,1 Michael B Zemel1,21NuSirt Sciences Inc, 2Department of Nutrition, University of Tennessee, Knoxville, TN, USABackground: The purpose of this study was to determine whether a mixture of the polyphenol, resveratrol, and the leucine metabolite, hydroxymethylbutyrate (HMB), acts syner...

Full description

Bibliographic Details
Main Authors: Bruckbauer A, Zemel MB
Format: Article
Language:English
Published: Dove Medical Press 2013-02-01
Series:Diabetes, Metabolic Syndrome and Obesity
Online Access:http://www.dovepress.com/synergistic-effects-of-metformin-resveratrol-and-hydroxymethylbutyrate-a12205
_version_ 1797936053605105664
author Bruckbauer A
Zemel MB
author_facet Bruckbauer A
Zemel MB
author_sort Bruckbauer A
collection DOAJ
description Antje Bruckbauer,1 Michael B Zemel1,21NuSirt Sciences Inc, 2Department of Nutrition, University of Tennessee, Knoxville, TN, USABackground: The purpose of this study was to determine whether a mixture of the polyphenol, resveratrol, and the leucine metabolite, hydroxymethylbutyrate (HMB), acts synergistically with low doses of metformin to impact insulin sensitivity and AMP-activated protein kinase-dependent outcomes in cell culture and in diabetic mice.Methods: C2C12 skeletal myotubes and 3T3-L1 adipocytes were treated with resveratrol 0.2 µM, HMB 5 µM, and metformin 0.1 mM alone or in combination. db/db mice were treated for 2 weeks with high (1.5 g/kg diet), low (0.75 g/kg diet), or very low (0.25 g/kg diet) doses of metformin alone or in combination with a diet containing resveratrol 12.5 mg and CaHMB 2 g/kg.Results: The combination of metformin-resveratrol-HMB significantly increased fat oxidation, AMP-activated protein kinase, and Sirt1 activity in muscle cells compared with metformin or resveratrol-HMB alone. A similar trend was found in 3T3L1 adipocytes. In mice, the two lower doses of metformin exerted no independent effect but, when combined with resveratrol-HMB, both low-dose and very low-dose metformin improved insulin sensitivity (HOMAIR), plasma insulin levels, and insulin tolerance test response to a level comparable with that found for high-dose metformin. In addition, the metformin-resveratrol-HMB combination decreased visceral fat and liver weight in mice.Conclusion: Resveratrol-HMB combined with metformin may act synergistically on AMP-activated protein kinase-dependent pathways, leading to increased insulin sensitivity, which may reduce the therapeutic doses of metformin necessary in the treatment of diabetes.Keywords: diabetes, AMP-activated protein kinase, Sirt1, fat oxidation
first_indexed 2024-04-10T18:23:39Z
format Article
id doaj.art-a2d3d707b67948648c485fb43491b6b4
institution Directory Open Access Journal
issn 1178-7007
language English
last_indexed 2024-04-10T18:23:39Z
publishDate 2013-02-01
publisher Dove Medical Press
record_format Article
series Diabetes, Metabolic Syndrome and Obesity
spelling doaj.art-a2d3d707b67948648c485fb43491b6b42023-02-02T06:44:28ZengDove Medical PressDiabetes, Metabolic Syndrome and Obesity1178-70072013-02-012013default93102Synergistic effects of metformin, resveratrol, and hydroxymethylbutyrate on insulin sensitivityBruckbauer AZemel MBAntje Bruckbauer,1 Michael B Zemel1,21NuSirt Sciences Inc, 2Department of Nutrition, University of Tennessee, Knoxville, TN, USABackground: The purpose of this study was to determine whether a mixture of the polyphenol, resveratrol, and the leucine metabolite, hydroxymethylbutyrate (HMB), acts synergistically with low doses of metformin to impact insulin sensitivity and AMP-activated protein kinase-dependent outcomes in cell culture and in diabetic mice.Methods: C2C12 skeletal myotubes and 3T3-L1 adipocytes were treated with resveratrol 0.2 µM, HMB 5 µM, and metformin 0.1 mM alone or in combination. db/db mice were treated for 2 weeks with high (1.5 g/kg diet), low (0.75 g/kg diet), or very low (0.25 g/kg diet) doses of metformin alone or in combination with a diet containing resveratrol 12.5 mg and CaHMB 2 g/kg.Results: The combination of metformin-resveratrol-HMB significantly increased fat oxidation, AMP-activated protein kinase, and Sirt1 activity in muscle cells compared with metformin or resveratrol-HMB alone. A similar trend was found in 3T3L1 adipocytes. In mice, the two lower doses of metformin exerted no independent effect but, when combined with resveratrol-HMB, both low-dose and very low-dose metformin improved insulin sensitivity (HOMAIR), plasma insulin levels, and insulin tolerance test response to a level comparable with that found for high-dose metformin. In addition, the metformin-resveratrol-HMB combination decreased visceral fat and liver weight in mice.Conclusion: Resveratrol-HMB combined with metformin may act synergistically on AMP-activated protein kinase-dependent pathways, leading to increased insulin sensitivity, which may reduce the therapeutic doses of metformin necessary in the treatment of diabetes.Keywords: diabetes, AMP-activated protein kinase, Sirt1, fat oxidationhttp://www.dovepress.com/synergistic-effects-of-metformin-resveratrol-and-hydroxymethylbutyrate-a12205
spellingShingle Bruckbauer A
Zemel MB
Synergistic effects of metformin, resveratrol, and hydroxymethylbutyrate on insulin sensitivity
Diabetes, Metabolic Syndrome and Obesity
title Synergistic effects of metformin, resveratrol, and hydroxymethylbutyrate on insulin sensitivity
title_full Synergistic effects of metformin, resveratrol, and hydroxymethylbutyrate on insulin sensitivity
title_fullStr Synergistic effects of metformin, resveratrol, and hydroxymethylbutyrate on insulin sensitivity
title_full_unstemmed Synergistic effects of metformin, resveratrol, and hydroxymethylbutyrate on insulin sensitivity
title_short Synergistic effects of metformin, resveratrol, and hydroxymethylbutyrate on insulin sensitivity
title_sort synergistic effects of metformin resveratrol and hydroxymethylbutyrate on insulin sensitivity
url http://www.dovepress.com/synergistic-effects-of-metformin-resveratrol-and-hydroxymethylbutyrate-a12205
work_keys_str_mv AT bruckbauera synergisticeffectsofmetforminresveratrolandhydroxymethylbutyrateoninsulinsensitivity
AT zemelmb synergisticeffectsofmetforminresveratrolandhydroxymethylbutyrateoninsulinsensitivity